HomeCategoryNewsNorway: Curida announces growth investment and appoints new CEO
NewsPeoplePharmaServices - CRO/CMO/CDMO

Norway: Curida announces growth investment and appoints new CEO

By Nick Herbert
-
Ole J Dahlberg and Anders Larsson

Curida, a CDMO focusing on aseptic and non-aseptic liquid manufacturing, has announced a significant growth investment from Signet Healthcare Partners, a New York-based healthcare private equity firm, together with existing…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Previous article
The Netherlands: Care Property Invest completes two Dutch projects
Next article
Effective use of AI in healthcare environments requires clinician trust
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Advertisement

Related Resources

Related Events